Qi Qi
Impact in
- Biological Psychiatry top 2%
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Natural product bioactivities and synthesis 13
- Circular RNAs in diseases 12
- RNA modifications and cancer 12
-
- Natural Compound Pharmacology Studies 19
- Co-authors
- Qinglong Guo (41 shared papers)Qidong You (35 shared papers)Na Lu (31 shared papers)Zhen Chen (8 shared papers)Hong-Yan Gu (20 shared papers)Yong Yang (21 shared papers)Yawen Geng (5 shared papers)Xiaotang Wang (10 shared papers)
- Journals
- Acta Pharmacologica Sinica (9 papers)Cancer Letters (8 papers)Biochemical Pharmacology (6 papers)Scientific Reports (6 papers)European Journal of Pharmacology (5 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Qi Qi
377 papers receiving 8.8k citations
Qi Qi's Hit Papers
Peers
Comparison fields: 5 of 177
- Biological Psychiatry 200
- Cancer Research 1.0k
- Pharmacology 1.1k
- Oncology 1.4k
- Molecular Biology 3.5k
Countries citing papers authored by Qi Qi
This map shows the geographic impact of Qi Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Qi more than expected).
Fields of papers citing papers by Qi Qi
This network shows the impact of papers produced by Qi Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Qi. The network helps show where Qi Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Qi Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 386 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy Hit paper breakdown → | 2016 | 473 |
| 2 | m6A modification: recent advances, anticancer targeted drug discovery and beyond Hit paper breakdown → | 2022 | 265 |
| 3 | 2009 | 173 | |
| 4 | 2021 | 165 | |
| 5 | 2019 | 160 | |
| 6 | 2020 | 127 | |
| 7 | 2015 | 107 | |
| 8 | 2016 | 97 | |
| 9 | 2005 | 96 | |
| 10 | 2008 | 95 | |
| 11 | 2018 | 95 | |
| 12 | 2021 | 90 | |
| 13 | 2015 | 87 | |
| 14 | 2019 | 87 | |
| 15 | 2019 | 85 | |
| 16 | 2008 | 85 | |
| 17 | 2009 | 83 | |
| 18 | 2015 | 81 | |
| 19 | 2008 | 78 | |
| 20 | 2017 | 75 |
About Qi Qi
Qi Qi is a scholar working on Molecular Biology, Plant Science, Oncology, Cancer Research and Pharmacology, having authored 386 papers that have together received 8.9k indexed citations. Recurring topics across this work include Natural Compound Pharmacology Studies (19 papers), Cancer-related molecular mechanisms research (14 papers), Cancer-related Molecular Pathways (14 papers), Flavonoids in Medical Research (14 papers), Natural product bioactivities and synthesis (13 papers), Circular RNAs in diseases (12 papers), MicroRNA in disease regulation (12 papers) and RNA modifications and cancer (12 papers). The work is most often cited by research in Biological Psychiatry (200 citations), Cancer Research (1.0k citations), Pharmacology (1.1k citations), Oncology (1.4k citations) and Molecular Biology (3.5k citations). Qi Qi has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Qinglong Guo, Qidong You, Na Lu, Zhen Chen, Hong-Yan Gu, Yong Yang, Yawen Geng, Xiaotang Wang, Zhiqiang Meng and Jiaxu Chen. Their work appears in journals such as Acta Pharmacologica Sinica, Cancer Letters, Biochemical Pharmacology, Scientific Reports and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.